Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, for People with Type 2 Diabetes: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. The New England Journal of Medicine
This gives the best chance of success
Before you start taking IMAX, talk to your doctor about your medical history, especially if you have peptic ulcer, regional enteritis, or ulcerative colitis
By blocking NNMT, it shifts intracellular NAD+ and S-adenosylmethionine (SAM) levels, two cofactors tied to energy metabolism, redox balance, and gene regulation in laboratory models
Both approaches show effectiveness, with selection depending on injury characteristics
After reconstitution store 28C and use within 20 days